Data is not available at this time.
Toagosei Co., Ltd. is a diversified chemical manufacturer operating in Japan and internationally, with a portfolio spanning commodity chemicals, specialty polymers, adhesives, and performance materials. The company serves a broad range of industries, including agriculture, construction, electronics, and healthcare, through its five core segments: Commodity Chemicals, Polymer & Oligomer, Adhesive Material, Performance Chemicals, and Plastics. Its product lineup includes essential industrial chemicals like caustic soda and sulfuric acid, as well as higher-margin specialty offerings such as UV-curable resins and electronic materials. Toagosei maintains a balanced market position, leveraging stable demand for commodity chemicals while investing in innovation-driven segments like functional adhesives and advanced polymers. The company's vertically integrated operations and technical expertise in acrylic monomers and inorganic functional materials provide competitive differentiation in niche markets. While facing competition from larger global chemical players, Toagosei's regional focus and diversified product mix help mitigate cyclical risks inherent in the chemical industry.
Toagosei reported revenue of ¥167.6 billion for the period, with net income of ¥11.9 billion, reflecting a net margin of approximately 7.1%. The company generated ¥20.2 billion in operating cash flow, though capital expenditures of ¥22.0 billion resulted in negative free cash flow. The diluted EPS of ¥104.56 indicates reasonable earnings power relative to its market capitalization.
The company demonstrates moderate capital efficiency, with its specialty chemicals segments likely contributing disproportionately to profitability given their higher value-added nature. The negative free cash flow position suggests ongoing investment in capacity or R&D, though the ¥30.8 billion cash reserve provides liquidity. The capital expenditure intensity warrants monitoring for future returns on invested capital.
Toagosei maintains a conservative financial structure with ¥30.8 billion in cash against ¥12.3 billion of total debt, indicating strong liquidity. The net cash position supports financial flexibility, though the moderate debt level suggests some leverage. The balance sheet appears capable of sustaining current operations and supporting selective growth initiatives.
The company has demonstrated stable performance with a ¥60 per share dividend, yielding approximately 2.3% based on current share price. Growth prospects appear tied to expansion in higher-margin specialty chemicals and electronic materials, though the commodity chemicals segment provides baseline revenue stability. The dividend appears sustainable given current earnings and cash reserves.
With a market capitalization of ¥151.1 billion, the company trades at approximately 12.7x trailing earnings. The low beta of 0.274 suggests the market perceives Toagosei as relatively defensive within the chemicals sector. Valuation multiples appear reasonable given the company's mixed exposure to both cyclical and specialty chemical markets.
Toagosei's strategic advantages lie in its technical expertise in acrylic chemistry and diversified product applications across multiple industries. The outlook remains cautiously positive, with opportunities in electronic materials and specialty adhesives potentially offsetting commodity chemical volatility. The company's regional focus and R&D capabilities position it to capitalize on Japan's advanced manufacturing ecosystem while maintaining export opportunities.
Company filings, market data
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |